PC

Puissance Capital

North America, New York, United States, New York

Description

Puissance Capital Management is a global asset manager

Investor Profile

Puissance Capital has made 2 investments, with 1 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Biopharma
  • Pharmaceutical
  • Health Care
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Puissance Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Altamont Pharmaceutical Holdings
North America, California, United States, San Jose
Co-Investments: 1
Kearny Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
AC
North America, California, United States, Belmont
Co-Investments: 1
Point72
North America, Connecticut, United States, Stamford
Co-Investments: 1
Armistice Capital
North America, New York, United States, New York
Co-Investments: 1
Samlyn Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Puissance Capital often collaborate with?

RA
North America, United States
Shared Deals: 1

What are some of recent deals done by Puissance Capital?

Corvus Pharmaceuticals

Burlingame, California, United States

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityMay 2, 2024
Amount Raised: $30,600,000
ViewRay

Oakwood, Ohio, United States

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityJan 18, 2017
Amount Raised: $26,100,000